Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ALOSETRON vs ALPELISIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ALOSETRON vs ALPELISIB: Safety Overview

Metric ALOSETRON ALPELISIB
Total FAERS Reports 141 8,419
Deaths Reported 8 1,271
Death Rate 5.7% 15.1%
Hospitalizations 12 1,705
Average Patient Age 63.6 yrs 58.8 yrs
% Female Patients 84.0% 94.7%
FDA Approval Date Dec 22, 2016 Apr 24, 2024
Manufacturer AvKARE Novartis Pharmaceuticals Corporation
Route ORAL ORAL
Marketing Status Prescription Prescription